title: Effect of intravenous immunoglobulin in Lambert-Eaton myasthenic syndrome with small-cell lung cancer: correlation with the titer of anti-voltage-gated calcium channel antibody.
authors.affiliation: Department of Neurology, Niigata University, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Takano
authors.forename: M
authors.initials: M
authors.lastname: Tanaka
authors.forename: R
authors.initials: R
authors.lastname: Koike
authors.forename: H
authors.initials: H
authors.lastname: Nagai
authors.forename: M
authors.initials: M
authors.lastname: Arakawa
authors.forename: S
authors.initials: S
authors.lastname: Tsuji
mesh_terms: D000200:Action Potentials; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D015220:Calcium Channels / Q000276:immunology*; D018288:Carcinoma, Small Cell / Q000150:complications* / Q000503:physiopathology / Q000628:therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood*; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D015624:Lambert-Eaton Myasthenic Syndrome / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D008175:Lung Neoplasms / Q000150:complications* / Q000503:physiopathology / Q000628:therapy; D008297:Male; D009132:Muscles / Q000503:physiopathology*; D010956:Plasmapheresis
chemical_list: D015220:Calcium Channels; D007074:Immunoglobulin G; D016756:Immunoglobulins, Intravenous; D005047:Etoposide; D003520:Cyclophosphamide